The REPROCELL Blog
Latest
ec23: A Promising ATRA Alternative for Advancing Stem Cell Research
13 December 2023
Quality Control: What is really in your hiPSC culture?
11 December 2023
Exploring CHIR99021: The Key to Stem Cell Research and Beyond
20 November 2023
Data Privacy and Protection in AI for Precision Medicine
31 October 2023
Bias in AI for precision medicine
02 October 2023
Stem cell and drug discovery scientists around the world are using REPROCELL’s services and products in their preclinical and clinical research.
Drug Discovery
Data Privacy and Protection in AI for Precision Medicine
31 October 2023
Bias in AI for precision medicine
02 October 2023
Wire myography: the ultimate guide [protocol included]
25 April 2023
Stem Cells
Quality Control: What is really in your hiPSC culture?
11 December 2023
Exploring CHIR99021: The Key to Stem Cell Research and Beyond
20 November 2023
Recombinant Human Laminins and their Use in Cell Culture
05 January 2023
Research Stem Cell Services
A complete portfolio of services for the reprogramming and differentiation of high-quality iPSCs.
Clinical Stem Cell Services
iPSC and MSC GMP Master Cell Banks and Clinical Cell Product Manufacturing.
StemEdit – Clinical Gene Editing Service
Using CRISPR-SNIPER, the most efficient gene-editing technique.
Clinical Capabilities
Data Privacy and Protection in AI for Precision Medicine
31 October 2023
Bias in AI for precision medicine
02 October 2023
Clinical Trials: An Evolutionary Perspective
18 January 2023
Human Tissue Samples
REPROCELL: What makes our biobank stand out?
04 August 2022
Tissue Sourcing for the Development of iPSC-derived Disease Models
06 February 2019